Achieve Life Sciences, Inc.(ACHV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ACHV Achieve Life Sciences, Inc.

Trading 03-26 11:06:21 EDT

2.97

+0.11

+3.67%

High2.97	Low2.83	Vol51.71K
Open2.85	D1 Closing2.86	Amplitude4.90%
Mkt Cap102.84M	Tradable Cap87.22M	Total Shares34.69M
T/O148.85K	T/O Rate0.18%	Tradable Shares29.42M
P/B4.92	ROE-409.51%	EPS-1.24
52wk High5.59	52wk Low2.51	P/E-2.39
Dividend0.00	Div.Yield0.00	ROA-84.19%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ACHV","market":"US","secType":"STK","nameCN":"Achieve Life Sciences, Inc.","latestPrice":2.965,"timestamp":1743001558240,"preClose":2.86,"halted":0,"volume":51705,"delay":0,"floatShares":29417855,"shares":34685072,"eps":-1.241832,"marketStatus":"Trading","change":0.105,"latestTime":"03-26 11:06:19 EDT","open":2.85,"high":2.97,"low":2.83,"amount":148845.241359,"amplitude":0.048951,"askPrice":2.97,"askSize":16,"bidPrice":2.95,"bidSize":410,"shortable":3,"etf":0,"ttmEps":-1.241832,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743019200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.86,"postHourTrading":{"tag":"盘后","latestPrice":2.86,"preClose":2.86,"latestTime":"17:46 EDT","volume":1799,"amount":5148,"timestamp":1742939164185},"volumeRatio":1.10096,"impliedVol":0.5168,"impliedVolPercentile":0.188},"requestUrl":"/m/hq/s/ACHV/wiki","defaultTab":"wiki","newsList":[{"id":"2521490202","title":"Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2521490202","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521490202?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 06:25","pubTimestamp":1742509517,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Achieve Life Sciences, Inc.  on Substack by Rogue Funds. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc. 's share was trading at $2.67 as of March 19th.Adding further conviction to the thesis, Achieve recently appointed new investment banking board members and has secured funding through Q3 2025, signaling potential strategic interest, including a buyout scenario. If Cytisinicline receives priority review, PDUFA could be scheduled for late 2025, catalyzing significant price appreciation. Given its breakthrough designation, compelling efficacy, and safety,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-222517983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ACHV"],"gpt_icon":0},{"id":"2518055846","title":"Q4 2024 Achieve Life Sciences Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2518055846","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518055846?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 15:14","pubTimestamp":1741763651,"startTime":"0","endTime":"0","summary":"Nicole Jones; Investor Relations; Achieve Life Sciences Inc. Richard Stewart; Chairman of the Board, Chief Executive Officer; Achieve Life Sciences Inc. Cindy Jacobs; President, Chief Medical Officer; Achieve Life Sciences Inc. Jaime Xinos; Chief Commerical Officer; Achieve Life Sciences Inc. Mark Oki; Chief Financial Officer; Achieve Life Sciences Inc. Greetings and welcome to the Achieve Life Sciences fourth-quarter and year-end 2024 earnings call and webcast.  As a reminder, this conference is being recorded.I would now like to turn the conference over to your host Nicole Jones, Achieve Investor Relations. Thank you. You may begin.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-achieve-life-sciences-071411880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACHV"],"gpt_icon":0},{"id":"2518055361","title":"Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2518055361","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518055361?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 15:02","pubTimestamp":1741762959,"startTime":"0","endTime":"0","summary":"Cash Equivalents and Marketable Securities: $34.4 million as of December 31, 2024, up from $15.6 million on December 31, 2023.Operating Expenses: $12.2 million for Q4 2024 and $39.1 million for the year ended December 31, 2024.Net Loss: $12.4 million for Q4 2024 and $39.8 million for the year ended December 31, 2024.Cash Runway: Sufficient to provide runway into the third quarter of 2025.GuruFocus has detected 2 Warning Sign with ACHV.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Achieve Life Sciences Inc  plans to submit the NDA for Cytisinicline as a treatment for nicotine dependence by the end of the next quarter.Cytisinicline has received breakthrough therapy designation for vaping cessation, highlighting its potential impact.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-070239677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACHV"],"gpt_icon":0},{"id":"2518333774","title":"Analysts Are Bullish on Top Healthcare Stocks: Achieve Life Sciences (ACHV), Dexcom (DXCM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518333774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518333774?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 03:50","pubTimestamp":1741722616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV – Research Report) and D...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-achieve-life-sciences-achv-dexcom-dxcm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-achieve-life-sciences-achv-dexcom-dxcm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0354030511.USD","BK4588","IE00BMPRXN33.USD","ACHV","LU0266013472.USD","LU0354030438.USD","BK4504","DXCM","BK4551","LU2125909247.SGD","LU1923622614.USD","BK4548","HCSG","BK4585","LU2433249047.HKD","BK4082","IE00BMPRXR70.SGD","LU2211815571.USD","LU2125909593.SGD","BK4139","BK4534","BK4137"],"gpt_icon":0},{"id":"2518490107","title":"Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518490107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518490107?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 21:19","pubTimestamp":1741699185,"startTime":"0","endTime":"0","summary":"Lake Street analyst Thomas Flaten maintained a Buy rating on Achieve Life Sciences (ACHV – Research Report) today and set a price target of $11.00....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-achieve-life-sciences-achv-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-achieve-life-sciences-achv-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACHV"],"gpt_icon":0},{"id":"2518177667","title":"Achieve Life Sciences Q4 EPS $(0.36) Misses $(0.32) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518177667","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518177667?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 19:36","pubTimestamp":1741692960,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.32) by 12.5 percent. This is a 38.46 percent decrease over losses of $(0.26) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44243528/achieve-life-sciences-q4-eps-0-36-misses-0-32-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Achieve Life Sciences Q4 EPS $(0.36) Misses $(0.32) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHV"],"gpt_icon":0},{"id":"2518471593","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471593?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:00","pubTimestamp":1741687200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Allbirds Inc. Class A                           4Q       4:05 PM. ·Dick's Sporting Gds                              4Q      3.52   7:00 AM. ·E. W. Scripps Co                                 4Q      1.01       AMC. ·European Wax Ctr                                4Q       .06   6:00 AM. ·First Watch Rest                                4Q       .01   7:00 AM. ·Kanzhun Ltd. Sp ADR                               4Q       .22       BMO","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BW","ACHV","KALV","MNTK","MGTX","ONDS","APYX","SID","TH","LEGN","RMBL","BBCP","S","ZYXI","SKYX","SPRB","UNFI","KSS","NOA","AKBA","AFCG","EBR","FTCI","SSP","KFY","BIRD","ABM","BTMD","WEST","BZ","ASRT","HLLY","ARCO","PHLT","DRUG","KRMD","WSM","AGEN","ATLC","EWCZ","BLDE","SKIN","LRMR","BWAY","SMSI","EXK","VTS","DKS","QRHC"],"gpt_icon":1},{"id":"2517438892","title":"Achieve Life Sciences Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517438892","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517438892?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 21:22","pubTimestamp":1741353727,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences Inc  expected to post a loss of32cents a share - Earnings Preview Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to show no change in quarterly revenue when it reports  res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ162:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHV"],"gpt_icon":0},{"id":"2517799157","title":"Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517799157","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517799157?lang=en_us&edition=full_marsco","pubTime":"2025-03-06 21:30","pubTimestamp":1741267800,"startTime":"0","endTime":"0","summary":"SEATTLE and VANCOUVER, British Columbia, March 06, 2025  -- Achieve Life Sciences, Inc. , a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tuesday, March 11, 2025, at 8:30 AM EDT.Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in treating nicotine addiction for smoking and e-cigarette cessation by interacting with nicotine receptors in the brain, reducing the severity of nicotine craving symptoms, and reducing the reward and satisfaction associated with nicotine products. Cytisinicline is an investigational product candidate being developed for the treatment of nicotine addiction and has not been approved by the Food and Drug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/achieve-life-sciences-announce-fourth-133000972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4588","BK4218","BK4585","ACHV","HST","BK4181"],"gpt_icon":0},{"id":"2512151743","title":"Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512151743","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512151743?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 20:29","pubTimestamp":1739881755,"startTime":"0","endTime":"0","summary":"Rogue Funds, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.59% net of fees in the quarter. This quarter, the Fund's volatility has increased significantly, and the firm anticipates that it will continue to do so. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024.In its fourth quarter 2024 investor letter, Rogue Funds emphasized stocks such as Achieve Life Sciences, Inc. . Achieve Life Sciences, Inc.  is a clinical-stage pharmaceutical company. The one-month return of Achieve Life Sciences, Inc.  was 10.68%, and its shares lost 20.83% of their value over the last 52 weeks. On February 14, 2025, Achieve Life Sciences, Inc.  stock closed at $3.42 per share with a market capitalization of $117.613 million.Rogue Funds stated the following regarding Achieve Life Sciences, Inc.  in its Q4 2024 investor letter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rogue-funds-updates-achieve-life-122915877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","QLD","PSQ","TSYW.SI","NQmain","BK4139","NVIW.SI","QID","USAW.SI","USJW.SI","ACHV","SQQQ",".IXIC","MNQmain"],"gpt_icon":1},{"id":"2510868709","title":"Achieve Life Sciences (ACHV) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2510868709","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510868709?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 22:26","pubTimestamp":1739197575,"startTime":"0","endTime":"0","summary":"Lake Street analyst Thomas Flaten reiterated a Buy rating on Achieve Life Sciences (ACHV – Research Report) today and set a price target of $11.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/achieve-life-sciences-achv-gets-a-buy-from-lake-street-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/achieve-life-sciences-achv-gets-a-buy-from-lake-street-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ACHV"],"gpt_icon":0},{"id":"2510522518","title":"Achieve Life Sciences Inc - Reiterates Planned Nda Submission for Cytisinicline in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510522518","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510522518?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:30","pubTimestamp":1739194200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA289XX1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACHV"],"gpt_icon":0},{"id":"2510252852","title":"Achieve Life Sciences Inc - Dsmc Finds No Unexpected Adverse Events in Orca-Ol Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2510252852","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510252852?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:30","pubTimestamp":1739194200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA289XX1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACHV"],"gpt_icon":0},{"id":"2510185297","title":"Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the Orca-Ol Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2510185297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510185297?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:30","pubTimestamp":1739194200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA289XX1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACHV"],"gpt_icon":0},{"id":"2510857314","title":"Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2510857314","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510857314?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:30","pubTimestamp":1739194200,"startTime":"0","endTime":"0","summary":"No Safety Concerns Identified by DSMC in the ORCA-OL Long-Term Exposure Trial. Achieve Reiterates Planned Cytisinicline NDA Submission in Q2 2025. SEATTLE and VANCOUVER, British Columbia, Feb. 10, 2025  -- Achieve Life Sciences, Inc. , a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that the Data Safety Monitoring Committee  has recently completed its second independent review of the ongoing ORCA-OL trial, evaluating long-term exposure of the novel 3 mg cytisinicline treatment dosing regimen in individuals who smoke cigarettes or vape nicotine.The ORCA-OL clinical trial is designed to satisfy the U.S. Food and Drug Administration’s  long-term exposure safety data requirements for cytisinicline’s potential approval. The FDA requested six-month safety exposure data from at least 300 participants who have been treated with cytisinicline to be included in th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/achieve-life-sciences-announces-positive-133000683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACHV","BK4139","DSMC"],"gpt_icon":0},{"id":"2506989370","title":"Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2506989370","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506989370?lang=en_us&edition=full_marsco","pubTime":"2025-01-25 01:14","pubTimestamp":1737738891,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Achieve Life Sciences, Inc.  on Substack by Jacob Rowe. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc. 's share was trading at $3 as of Jan 23rd.Achieve Life Sciences, Inc.  is not on our list of the30 Most Popular Stocks Among Hedge Funds. As per our database, 6 hedge fund portfolios held ACHV at the end of the third quarter which was 7 in the previous quarter. While we acknowledge the risk and potential of ACHV as an investment, our conviction lies in the belief that some AI stocks hold greater promise f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/achieve-life-sciences-inc-achv-171451275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACHV","BK4139"],"gpt_icon":0},{"id":"2505277306","title":"ACHV: Long-Term Exposure Requirement Complete","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277306","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505277306?lang=en_us&edition=full_marsco","pubTime":"2025-01-21 17:58","pubTimestamp":1737453480,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences, Inc.  has been busy since its previous quarterly update, adding new board members and executives and completing the long-term portion of its ORCA OL study which will generate critical safety data to be used in the new drug application  for smoking cessation. The R&D team held the end of Phase II  meeting with the FDA to finalize the study design for the pivotal vaping trial. Management has shared its recent accomplishments at investor events including the Jefferies London Healthcare conference in November and the Piper Sandler Healthcare conference in December in New York. Management also participated in one-on-one meetings during the JP Morgan Healthcare Conference in San Francisco in January.The completed study will include safety data on at least 300 subjects that have received cumulative cytisinicline treatment for six months. After the 300 subjects complete six months of treatment, Achieve expects a three-month turnaround to collect the data, analyze it and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/achv-long-term-exposure-requirement-095800350.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","DSMC","ACHV"],"gpt_icon":0},{"id":"2502895869","title":"Achieve Life Sciences appoints Slaoui, Phelan to board of directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2502895869","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502895869?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 21:47","pubTimestamp":1736516824,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences (ACHV) announced that Kristen Slaoui, Ph.D., and Nancy Phelan will join its Board of Directors. Achieve also announced that c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/achieve-life-sciences-appoints-slaoui-phelan-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/achieve-life-sciences-appoints-slaoui-phelan-to-board-of-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ACHV"],"gpt_icon":0},{"id":"2502865188","title":"Achieve Life Sciences Appoints DR. Kristen Slaoui and Nancy Phelan to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2502865188","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502865188?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 21:30","pubTimestamp":1736515802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA1K82QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACHV","BK4139"],"gpt_icon":0},{"id":"2502865235","title":"Press Release: Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2502865235","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502865235?lang=en_us&edition=full_marsco","pubTime":"2025-01-10 21:30","pubTimestamp":1736515800,"startTime":"0","endTime":"0","summary":"New Directors Bring Extensive Leadership Experience in Corporate Strategy and Commercialization. SEATTLE and VANCOUVER, British Columbia, Jan. 10, 2025  -- Achieve Life Sciences, Inc. , a late-stage pharmaceutical company focused on the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Kristen Slaoui, Ph.D., and Nancy Phelan will join its Board of Directors. Achieve also announced that current Board member, Vaughn Himes, Ph.D., has retired and resigned from the Board. He will continue to provide consulting services to the company.Nancy R. Phelan brings over 25 years of executive leadership in the biopharma and service industries. Currently, Nancy serves as Senior Vice President at Trinity Life Sciences and on the boards of directors of Medexus Pharmaceuticals and FemmePharma. In her current role at Trinity Life S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHV","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.achievelifesciences.com","stockEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":-0.0978},{"period":"3month","weight":-0.2454},{"period":"6month","weight":-0.3559},{"period":"1year","weight":-0.3876},{"period":"ytd","weight":-0.1875}],"compareEarnings":[{"period":"1week","weight":0.0257},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.043},{"period":"6month","weight":0.0055},{"period":"1year","weight":0.1071},{"period":"ytd","weight":-0.0181}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.178474},{"month":2,"riseRate":0.5,"avgChangeRate":0.01287},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.024347},{"month":4,"riseRate":0.448276,"avgChangeRate":0.066693},{"month":5,"riseRate":0.448276,"avgChangeRate":0.215838},{"month":6,"riseRate":0.344828,"avgChangeRate":-0.064095},{"month":7,"riseRate":0.586207,"avgChangeRate":0.063438},{"month":8,"riseRate":0.310345,"avgChangeRate":-0.090687},{"month":9,"riseRate":0.37931,"avgChangeRate":-0.110931},{"month":10,"riseRate":0.275862,"avgChangeRate":-0.095662},{"month":11,"riseRate":0.7,"avgChangeRate":0.081416},{"month":12,"riseRate":0.466667,"avgChangeRate":-0.045902}],"exchange":"NASDAQ","name":"Achieve Life Sciences, Inc.","nameEN":"Achieve Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Achieve Life Sciences, Inc.(ACHV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Achieve Life Sciences, Inc.(ACHV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Achieve Life Sciences, Inc.,ACHV,Achieve Life Sciences, Inc.股票,Achieve Life Sciences, Inc.股票老虎,Achieve Life Sciences, Inc.股票老虎国际,Achieve Life Sciences, Inc.行情,Achieve Life Sciences, Inc.股票行情,Achieve Life Sciences, Inc.股价,Achieve Life Sciences, Inc.股市,Achieve Life Sciences, Inc.股票价格,Achieve Life Sciences, Inc.股票交易,Achieve Life Sciences, Inc.股票购买,Achieve Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Achieve Life Sciences, Inc.(ACHV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Achieve Life Sciences, Inc.(ACHV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction